US Stocks
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
$0.0006
+0.0000 (+0.00%)
Volume:
0 ($0.00)
Market Capitalization:
-
eFFECTOR Therapeutics Price Chart
*There is no price data available for this ticker
eFFECTOR Therapeutics Volume Chart
*There is no volume data available for this ticker
eFFECTOR Therapeutics Market Segments
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
*No Trades in Segment
Premarket Yesterday
*No Trades in Segment
eFFECTOR Therapeutics News
There is no current news for this stock at the moment.
eFFECTOR Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
eFFECTOR Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.0006 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.0005 |
| 20 Day Moving Average (SMA20) | $0.0004 |
| 50 Day Moving Average (SMA50) | $0.0003 |
| 100 Day Moving Average (SMA100) | $0.0003 |
| 200 Day Moving Average (SMA200) | $0.0004 |
eFFECTOR Therapeutics Statistics
| Average Volume (30 Days) | 5.61K |
|---|---|
| P/E Ratio (Current) | .00 |
| EPS (Current) | -$7.36 |
| Dividend Yield | — |
| Free Cash Flow | -$29.28M |
| Cash Ratio | 0.61 |
| Current Ratio | 1.03 |
| Quick Ratio | 1.03 |
| Debt to Equity | 24.20 |
| Enterprise Value | $4.51M |
| EV to EBITDA | -0.14 |
| EV to Sales | — |
| Price to Book | 0.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.28% |
| Return on Equity | -41.88% |
eFFECTOR Therapeutics Stock Splits
There has been 1 stock split for eFFECTOR Therapeutics (EFTR). The reverse stock split occured on January 12, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 12, 2024 | Reverse | 25:1 |
eFFECTOR Therapeutics Dividends
There have been no dividends for eFFECTOR Therapeutics (EFTR).